Atypical brain asymmetry in autism - a candidate for clinically meaningful stratification

  • Background: Autism spectrum disorder (“autism”) is a highly heterogeneous neurodevelopmental condition with few effective treatments for core and associated features. To make progress we need to both identify and validate neural markers that help to parse heterogeneity to tailor therapies to specific neurobiological profiles. Atypical hemispheric lateralization is a stable feature across studies in autism, but its potential as a neural stratification marker has not been widely examined. Methods: In order to dissect heterogeneity in lateralization in autism, we used the large EU-AIMS (European Autism Interventions—A Multicentre Study for Developing New Medications) Longitudinal European Autism Project dataset comprising 352 individuals with autism and 233 neurotypical control subjects as well as a replication dataset from ABIDE (Autism Brain Imaging Data Exchange) (513 individuals with autism, 691 neurotypical subjects) using a promising approach that moves beyond mean group comparisons. We derived gray matter voxelwise laterality values for each subject and modeled individual deviations from the normative pattern of brain laterality across age using normative modeling. Results: Individuals with autism had highly individualized patterns of both extreme right- and leftward deviations, particularly in language, motor, and visuospatial regions, associated with symptom severity. Language delay explained most variance in extreme rightward patterns, whereas core autism symptom severity explained most variance in extreme leftward patterns. Follow-up analyses showed that a stepwise pattern emerged, with individuals with autism with language delay showing more pronounced rightward deviations than individuals with autism without language delay. Conclusions: Our analyses corroborate the need for novel (dimensional) approaches to delineate the heterogeneous neuroanatomy in autism and indicate that atypical lateralization may constitute a neurophenotype for clinically meaningful stratification in autism.
Metadaten
Author:Dorothea L. FlorisORCiDGND, Thomas WolfersORCiDGND, Mariam ZabihiORCiD, Nathalie E. HolzORCiDGND, Marcel P. ZwiersORCiD, Tony CharmanORCiDGND, Julian TillmannORCiDGND, Christine EckerORCiD, Flavio Dell'AcquaORCiDGND, Tobias BanaschewskiORCiDGND, Carolin Ulrike MößnangORCiDGND, Simon Baron-CohenORCiDGND, Rosemary Holt, Sarah Durston, Eva LothORCiDGND, Declan G. M. MurphyORCiD, Andre F. MarquandORCiD, Jan K. BuitelaarORCiDGND, Christian F. BeckmannORCiDGND
URN:urn:nbn:de:hebis:30:3-627964
DOI:https://doi.org/10.1016/j.bpsc.2020.08.008
ISSN:2451-9030
Parent Title (English):Biological psychiatry: Cognitive neuroscience and neuroimaging
Publisher:Elsevier Inc.
Place of publication:Amsterdam [u.a.]
Document Type:Article
Language:English
Date of Publication (online):2020/08/25
Date of first Publication:2020/08/25
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:EU-AIMS Longitudinal European Autism Project Group
Release Date:2022/07/04
Tag:Autism spectrum disorder; Brain asymmetry; Hemispheric specialization; Heterogeneity; Language delay; Normative modeling
Volume:6.2020
Issue:8
Page Number:11
First Page:802
Last Page:812
Note:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement Nos 115300 (for EU-AIMS) and 777394 (for AIMS-2-TRIALS). This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme, the European Federation of Pharmaceutical Industries and Associations, Autism Speaks, Autistica, and the Simons Foundation Autism Research Initiative. This work was also supported by the Netherlands Organisation for Scientific Research through Vidi grants (Grant Nos. 864.12.003 [to CFB] and 016.156.415 [to AM]), the Seventh Framework Programme (Grant Nos. 602805 [AGGRESSOTYPE] [to JKB], 603016 [MATRICS] [to JKB], and 278948 [TACTICS] [to JKB]), and the European Community’s Horizon 2020 Programme (H2020/2014-2020) (Grant Nos. 643051 [MiND] and 642996 [BRAINVIEW]). This work also received funding from the Wellcome Trust U.K. Strategic Award (Award No 098369/Z/12/Z) and the National Institute for Health Research Maudsley Biomedical Research Centre (to DGMM). TW gratefully acknowledges grant support from the Niels Stensen Fellowship. NEH gratefully acknowledges grant support from the German Research Foundation (Grant Nos. DFG HO 5674/2-1 and GRK2350/1) and the Olympia Morata Program of the University of Heidelberg. SB-C was funded by the Autism Research Trust, the Wellcome Trust, the Templeton World Charitable Foundation, and the National Institute for Health Research Biomedical Research Centre in Cambridge during the period of this work. TC has received consultancy fees from Roche and book royalties from Guildford Press and Sage.
HeBIS-PPN:497224089
Institutes:Medizin
Dewey Decimal Classification:1 Philosophie und Psychologie / 15 Psychologie / 150 Psychologie
6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0